Showing 41-50 of 58 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Transcriptional memory in human islet organogenesis | Lundquist Institute for Biomedical Medical Innovation at Harbor‐UCLA Medical Center (The Lundquist Institute) | Eiji Yoshihara | Cures | 01-April-2022 to 31-March-2027 | $749,995.50 |
| Creation of a Commercializable Multi-Omics Resource from T1D Patient-Derived iPSC-Derived 3D Islet Organoid Models | Greenstone Biosciences, Inc. | Angelos Oikonomopoulos | Cures | 25-June-2026 to 24-June-2029 | $1,200,000.00 |
| ENCRT-hPI (Immune-Protected ENCRT Extension Study), Evaluation of an immune-protected ENCRT-101 loaded with primary human islets in adults with Type 1 Diabetes, with and without standard-of-care portal vein islet infusion. | Encellin | Crystal Nyitray | Cures | 25-June-2026 to 24-June-2028 | $2,500,000.00 |
| IND Readiness Gap Analysis and Risk Assessment | Dark Horse Consulting | Amanda Mack | Cures | 15-June-2026 to 30-November-2026 | $80,325.05 |
| Broad Scope CMC, Non-Clinical, and Regulatory Support | Dark Horse Consulting | Nathan Manley | Cures | 01-September-2025 to 31-December-2026 | $85,000.00 |
| Engineering and Translational Control of Vascularization for Durable Islet Replacement Therapies | Cedars-Sinai Medical Center | Dhruv Sareen | Cures | 01-October-2026 to 30-September-2029 | $899,998.80 |
| Scalable GMP-Compliant Manufacturing of iPSC-Derived Insulin-Producing Cells: From Seed Train to Cryopreserved Product | Cedars-Sinai Medical Center | Dhruv Sareen | Cures | 01-April-2026 to 31-March-2028 | $600,000.00 |
| Cellular Sentinels of Islet Transplant Rejection | California Institute of Technology | Mikhail Shapiro | Cures | 01-July-2023 to 30-June-2027 | $750,000.00 |
| GLUT1 Inhibition in type 1 diabetes | Beckman Research Institute of the City of Hope | Alberto Pugliese | Cures | 01-November-2022 to 31-July-2026 | $494,072.25 |
| Combination therapy with STX4 activating small molecules or small activating RNA together with harmine to stimulate beta-cell regeneration and enhance functional beta-cell mass | Beckman Research Institute of the City of Hope | Debbie Thurmond | Cures | 01-October-2025 to 30-September-2028 | $1,050,000.00 |